Is Ampio Pharmaceuticals Inc. (AMPE) A Risky Investment?

MNDY Stock
MNDY Stock

Ampio Pharmaceuticals Inc. (AMEX:AMPE) finished Thursday with a subtraction of $0.0 to close at $0.08, an upside of 0.64 percent. An average of 7,583,840 shares of common stock have been traded in the last five days. There was a fall of -$0.0206 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 11,562,030 shares traded, while the 50-day average volume stands at 8,521,950.

AMPE stock has decreased by -9.61% in the last month. The company shares reached their 1-month lowest point of $0.0726 on 09/22/22. With the stock rallying to its 52-week high on 03/24/22, shares of the company touched a low of $0.07 and a high of $1.82 in 52 weeks. It has reached a new high 3 times so far this year and lost -86.30% or -$0.4919 in price. In spite of this, the price is down -95.71% from the 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Valuation Metrics

Ampio Pharmaceuticals Inc. (AMPE) stock’s beta is 1.75. Other valuation ratios to consider include the price-to-book (PB) ratio at 0.87.

Financial Health

The quick ratio of Ampio Pharmaceuticals Inc. for the three months ended March 30 was 4.80, and the current ratio was 4.80, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending March 30.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Ampio Pharmaceuticals Inc.’s return on assets was -57.90%.

Earnings Surprise

The company posted a net income of -$2.07 million in the quarter, while revenues of -$5.64 million were shrunk -71.98%. The analyst consensus anticipated Ampio Pharmaceuticals Inc.’s latest quarter earnings to come in at -$0.02 per share, but it turned out to be -$0.02, a 0.00% surprise. Shareholders own equity worth $226.29 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Ampio Pharmaceuticals Inc. (AMPE) price momentum. RSI 9-day as of the close on 22 September was 29.51%, suggesting the stock is oversold, with historical volatility in this time frame at 67.27%.

As of today, AMPE’s price is $0.0827 -20.87% or -$0.0206 from its 5-day moving average. AMPE is currently trading -16.11% lower than its 20-day SMA and -66.07% lower than its 100-day SMA. However, the stock’s current price level is -52.70% below the SMA50 and -92.34% below the SMA200.

The stochastic %K and %D were 8.44% and 8.29%, respectively, and the average true range (ATR) was 0.0101. With the 14-day stochastic at 10.20% and the average true range at 0.0110, the RSI (14) stands at 33.46%. The stock has reached -0.0104 on the 9-day MACD Oscillator while the 14-day reading was at -0.0121.

Analyst Ratings

ROTH Capital launched coverage on Ampio Pharmaceuticals Inc. (AMEX: AMPE) in its analyst report released on December 19, 2019. The firm assigned the stock a Buy rating.


Please enter your comment!
Please enter your name here